TIFFANY RICHARDSON: Open Payments
NPI 1275787053 · ELIZABETHTOWN, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,835 in 188 payments from 19 companies in 2025. Trend: 2023 $2,077 · 2024 $2,307 · 2025 $2,835
Food & beverage: $2,715Education: $120
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 46 | $676 |
| Janssen Biotech, Inc. | 30 | $445 |
| Ardelyx, Inc. | 20 | $367 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 10 | $192 |
| Gilead Sciences, Inc. | 14 | $178 |
| Phathom Pharmaceuticals, Inc. | 17 | $173 |
| Madrigal Pharmaceuticals | 11 | $158 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $150 |
| GENZYME CORPORATION | 6 | $116 |
| Ipsen Biopharmaceuticals, Inc | 4 | $78 |
Products named: TREMFYA, RINVOQ, IBSRELA, XIFAXAN, VOQUEZNA, DUPIXENT, REZDIFFRA, ENTYVIO.
Industry payments across KY — which companies pay providers there.
